Mesenteric Artery Embolism During Coronavirus Disease-19 (COVID-19) İn A Patient Previously Diagnosed With Fabry: A Case Report

Aladağ N., Akdemir Z., Çallı İ.

Eastern Journal of Medicine, cilt.28, sa.4, ss.832-835, 2023 (Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Sayı: 4
  • Basım Tarihi: 2023
  • Doi Numarası: 10.5505/ejm.2023.80270
  • Dergi Adı: Eastern Journal of Medicine
  • Derginin Tarandığı İndeksler: Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.832-835
  • Anahtar Kelimeler: Atrial fibrilation, COVID-19, Embolism, Fabry disease, Superior mesenteric artery
  • Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

We report a unique case of superior mesenteric artery embolism that developed in a patient with COVID-19 who was followed up with the diagnosis of Fabry Disease. On the 12th day of COVID-19 illness, atrial fibrillation and superior mesenteric artery embolism were detected in a 56-year-old male patient who was previously diagnosed with Fabry Disease. We did not find a similar patient in the literature. In the coexistence of Fabry Disease and COVID-19, risk of arrhythmia such as atrial fibrillation, which is the most common arrhythmia in both diseases, increases further. COVID-19 can cause arterial and venous thrombosis. In the coexistence of Fabry Disease and COVID-19, care should be taken against increased thrombogenicity, arrhythmia (such as atrial fibrillation) and thromboembolism that may develop due to them.